Review Article

Radiotracers Used for the Scintigraphic Detection of Infection and Inflammation

Table 4

Characteristics of selected radiotracers.

Radiotracer molecules Dose formulationRadiolabelingRadiotracer purification method
IsotopeIsotope chelatorCold moietyConditionsEfficiency

Synthetics
111InDTPAfMLFKSephadex G-10 eluentRT/30 min95%RP-HPLC
99mTcHYNICfMLFKSodium phosphate, saline, pH 8RT/30–60 min>96%RP-HPLC
99mTcHYNICMLF-OMeSodium phosphate, saline, pH 8RT/30–60 min>96%RP-HPLC
68GaNoneCitrateSodium citrate, pH 6-790°C/10 min>98%Anion exchange column
68GaNoneTAFC1.1 M sodium acetate, pH 6-7RT/15 min≥95%
68GaNoneFOXE1.1 M sodium acetate, pH 6-780°C/20 min≥95%
111InDTPALTB-4
(DPC11870-11)
Ammonium acetate, pH 5.5RT/30 min95%RP-HPLC
99mTcHYNICLTB-4 (MB88)Tricine, isonicotinic acid, PBS, SnSO4, pH 7100°C/30 min95%RP-HPLC
18FpFBALTB-4 (MB67)Sodium acetate, PBS, pH 4–750°C/>30 min65–85%Evaporation, & N2

Antibiotics
99mTcNoneFluconazolePYP, SnCl2, KBH4 in 0.1 M NaOH, saline, PBS, pH 7.5RT/120 min90%
99mTcNoneCiprofloxacinSn(II) tartrateRT/15 min>40%
99mTcNoneEnrofloxacinEthanol : water [1 : 1]60°C/10 min81%SepPak tC2 cartridge
99mTcNonePefloxacinSnCl2, pH 6100°C/30 min98%
99mTcNoneCeftizoximeSodium dithionite, N2100°C/5 min>90%
99mTcNoneVancomycinSnCl2, pH 6-7RT/10 min99%
99mTcNoneKanamycin SnCl2, pH 6-7RT/25–30 min99%
99mTcNoneAlafosfalinSnCl2, pH 6RT/5–10 min90–95%
99mTcNonePhosphomycinSnCl2, pH 7RT/<1 min98%
99mTcNoneCefoperazoneSnCl2, pH 8RT/10 min98%
99mTcNoneCefuroxime axetilSnCl2, pH 5RT/15 min92%
99mTc[99mTc(CO)5]NovobiocinWaterRT/30 min99%

Biological origin
Cells:
18FDGNoneLeukocytesAutologous LEuk, saline 37°C/30 min79% 18F-gran.Centrifugation
111InOxineDendritic cellsAllogeneic DC, salineRT/60 min94%Centrifugation
111InOxineLymphocytesAutologous LYM, lym poor plasma37°C/10 min77%Centrifugation
Macromolecules
111InDTPAhpc-IgGCitrateRT/instant>95%Centrifugation
99mTcNonehpc-IgGTartrate, SnCl2RT/20 min90%
99mTcHYNIChpc-IgGAcetate, tricine, SnSO4RT/15 min>95%
99mTcNoneRat pc-IgGMDP, SnCl2, PBS, N2RT/20 min≥94%
99mTcNoneHSASaline, SnCl2, N2, pH 2–7RT/20 min≥95%
99mTcNoneInfliximabMDP, SnCl2, PBS, N2RT/20 min≥91%
99mTcNoneFanolesomabMaltose, tartrate, succinic acid, Sn(II) tartrate, glycine, EDTA, ascorbic acid, pH 637°C/30 min≥90%
99mTcHYNICE-selectin peptide
(IMP-178)
2-OH--cyclodextrin, Sncl2, acetate, ascorbate RT/10 min; 100°C/15 min92%
123INoneB2702-p
(75–84)
PBS, pH 7RT/15 min>80%Anion exchange column
99mTc[99mTc(CO)5]B2702-p
(+his-gly)
PBS, pH 7100°C/15 min then 80°C/20 min>90%
99mTcHMPAOPEG-liposomes5% glucoseRT/15 min70–80%Size exclusion on PD-10 column
123INonehr-IL-10.5% BSA in PBSRT/10 min50–80%Sephadex G-25 column/0.2 m filter
123INonehr-IL-10.25% gelatine in PBSRT/10 min; ice/30 min25–35%Sephadex G-25 column/0.2 m filter
18F[para-18F-fluoroethyl]hr-IL-1raPBS38°C/45 min7–24%HiTrap column/filter
99mTcNoneIL-18bp-Fc-IL-1raPBS, pH 7RT/30 min>75%Sephadex G-25 column
99mTcHYNIChr-IL-2SnCl2, tricine, nicotinic acid, pH 6-7RT/<60 min>99%
123INonehr-IL-25% glucoseRT/30 min>96%HPLC; 30°C/20 min/N2
18FpFBAhr-IL-2Saline, <10% ethanolborate pH 8.5 : EtOH [1 : 1], 50°C/10 min25–35%RP-HPLC
99mTcHYNIChr-IL-8SnSO4, tricine, nicotinic acid, 0.5% BSA in PBS, pH 770°C/30 min>98%
99mTcHYNIChr-IL-12Stannous tartrate, tricine, pH 6-7RT/30 min75–85%G-50 microspin column
99mTc HYNICC5aSnSO4, tricine, 0.5% BSA in PBSRT/30 min >95%Sephadex G-25 column/0.2 m filter
99mTcC5adR
Smaller fragments:
99mTcNoneUBI-29-41Sn(II) PYP, potassium borohydride, NaOH, pH 5-6RT/60 min95%
99mTcHYNICUBI-29-41SnCl2, tricine, mannitol, pH 4RT/>60 min>96%

RT: room temperature; RP: reverse phase; HPLC: high pressure liquid chromatography; none: isotope is directly bound to the structure of the nonradioactive component; pFBA: para-18F-fluorobenzaldehydel; : heat; PBS: phosphate buffered saline; UBI: ubiquicidin; hpc: human polyclonal; IL: interleukin; hr: human recombinant; LT: leukotriene; DC: dendritic cells; LEuk: Leukocytes; LYM: Lymphocytes.